Vimarsana
Biggest News Aggregation in the World

Page 9 - Brian Goff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brian Goff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brian Goff Today - Breaking & Trending Today

Agios Appoints Tsveta Milanova as Chief Commercial Officer - Vimarsana News

Agios Appoints Tsveta Milanova as Chief Commercial Officer

CAMBRIDGE, Mass., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering...

Agios sells cancer drug royalty, raising $132M to fund rare disease mission - Vimarsana News

Agios sells cancer drug royalty, raising $132M to fund rare disease mission

Agios Pharmaceuticals sold royalties to an approved cancer drug to get immediate cash to support its new focus on rare diseases. Earlier this year, the FDA approved the biotech’s first rare disease drug, a treatment for a type of anemia.

Agios Appoints Rahul Ballal and Cynthia Smith to Board of - Vimarsana News

Agios Appoints Rahul Ballal and Cynthia Smith to Board of

CAMBRIDGE, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism pioneering...

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Executive Officer - Vimarsana News

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Executive Officer

09.08.2022 - CAMBRIDGE, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) - Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, today announced the grant of inducement equity ...

Agios Reports Inducement Grants Under Nasdaq Listing Rule - Vimarsana News

Agios Reports Inducement Grants Under Nasdaq Listing Rule

CAMBRIDGE, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering...